The oncology drugs market is expected to reach US$ 385.51 Billion by 2032.
The oncology drugs market is expected grow at a CAGR of 12.6% between 2023 to 2032.
The oncology drugs market was estimated to be US$ 118.13 Billion in 2022.
North America is predicted to continue to lead the regional segments over the forecast period of this report. North America, particularly the US, has the biggest demand for anti-cancer medications.
Major players operating in the global oncology drugs market include Amgen Inc., Johnson and Johnson, Roche Diagnostics, GlaxoSmithKline PLC, Merck & Company, Novartis AG, Pfizer, Sanofi, Eli Lilly and Company, Celgene Corporation, Bayer, Amgen, Merck, Bristol-Myers Squibb, Ariad Pharmaceuticals, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, and Teva Pharmaceuticals among others.
The oncology drugs analysis market has been assessed for the years 2019 to 2032.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved